Counterfeit Ovulen-21 case
According to FDA's March/April Case News the last defendent in the counterfeiting case, Sheldon Harwin, was sentenced on May 1 in Miami Federal Court to "11 consecutive years of incarceration." On March 14, Harwin was found guilty on five counts, which include conspiracy, causing the printing of counterfeit labels, and distribution of a counterfeit drug, FDA said. A total of seven persons have been prosecuted by FDA for distributing counterfeit Ovulen-21, the agency said. Two other defendents that were found guilty in 1987 are serving sentences of 24 years apiece ("The Pink Sheet" Dec. 5, 1988, T&G-17).
You may also be interested in...
Health technology assessment body NICE has now recommended that selective internal radiation therapy can be used on England’s National Health Service for treating advanced liver cancer.
A “structured dialog” led by the European Commission with pharmaceutical industry stakeholders provides a critical opportunity to address weaknesses in the stability and security of the supply chain by improving the environment for local manufacturing, Medicines for Europe believes.
Despite a slight increase in revenue, South Africa’s Adcock continues to struggle as it reports a continued drop in gross profit. The company expects the economy to remained constrained due to COVID-19, but is eagerly anticipating recovery with the government’s vaccine roll-out.